Susan C Chesire, ANP | |
3600 Gaston Ave, Wadley Tower, Suite 651, Dallas, TX 75246-1800 | |
(214) 820-9115 | |
(214) 820-9135 |
Full Name | Susan C Chesire |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 13 Years |
Location | 3600 Gaston Ave, Dallas, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003167982 | NPI | - | NPPES |
307523601 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LA2200X | Nurse Practitioner - Adult Health | 707057 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kingly Home Health Care Incorporated | Irving, TX | Home health agency |
Texas Home Health Skilled Services | Desoto, TX | Home health agency |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Healthtexas Provider Network | 1355254210 | 1810 |
News Archive
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus Zometa(R) (zoledronic acid) administered as an intravenous infusion in the treatment of bone metastases in 1,776 advanced cancer patients with solid tumors (not including breast and prostate cancer) or multiple myeloma. These results were presented today at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany (Abstract Number: 20LBA).
The presence in advanced breast cancer of mutational signatures characteristic of homologous recombination deficiency (HRD) was associated with improved clinical outcomes to treatment with platinum-based chemotherapy.
Bacteria responsible for middle ear infections, pink eye and sinusitis protect themselves from further immune attack by transporting molecules meant to destroy them away from their inner membrane target, according to a study from Nationwide Children's Hospital.
People living with HIV/AIDS in New Jersey could be negatively affected by prescription drug co-payments included in Gov. Jon Corzine's (D) proposed $29.8 billion budget, advocates told state lawmakers on Tuesday, the Newark Star-Ledger reports.
› Verified 7 days ago
Entity Name | Healthtexas Provider Network |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus Zometa(R) (zoledronic acid) administered as an intravenous infusion in the treatment of bone metastases in 1,776 advanced cancer patients with solid tumors (not including breast and prostate cancer) or multiple myeloma. These results were presented today at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany (Abstract Number: 20LBA).
The presence in advanced breast cancer of mutational signatures characteristic of homologous recombination deficiency (HRD) was associated with improved clinical outcomes to treatment with platinum-based chemotherapy.
Bacteria responsible for middle ear infections, pink eye and sinusitis protect themselves from further immune attack by transporting molecules meant to destroy them away from their inner membrane target, according to a study from Nationwide Children's Hospital.
People living with HIV/AIDS in New Jersey could be negatively affected by prescription drug co-payments included in Gov. Jon Corzine's (D) proposed $29.8 billion budget, advocates told state lawmakers on Tuesday, the Newark Star-Ledger reports.
› Verified 7 days ago
Entity Name | Nv Pacs 2 Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427534809 PECOS PAC ID: 0941550578 Enrollment ID: O20210820003080 |
News Archive
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus Zometa(R) (zoledronic acid) administered as an intravenous infusion in the treatment of bone metastases in 1,776 advanced cancer patients with solid tumors (not including breast and prostate cancer) or multiple myeloma. These results were presented today at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany (Abstract Number: 20LBA).
The presence in advanced breast cancer of mutational signatures characteristic of homologous recombination deficiency (HRD) was associated with improved clinical outcomes to treatment with platinum-based chemotherapy.
Bacteria responsible for middle ear infections, pink eye and sinusitis protect themselves from further immune attack by transporting molecules meant to destroy them away from their inner membrane target, according to a study from Nationwide Children's Hospital.
People living with HIV/AIDS in New Jersey could be negatively affected by prescription drug co-payments included in Gov. Jon Corzine's (D) proposed $29.8 billion budget, advocates told state lawmakers on Tuesday, the Newark Star-Ledger reports.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Susan C Chesire, ANP 3600 Gaston Ave, Wadley Tower, Suite 651, Dallas, TX 75246-1800 Ph: (214) 820-9115 | Susan C Chesire, ANP 3600 Gaston Ave, Wadley Tower, Suite 651, Dallas, TX 75246-1800 Ph: (214) 820-9115 |
News Archive
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus Zometa(R) (zoledronic acid) administered as an intravenous infusion in the treatment of bone metastases in 1,776 advanced cancer patients with solid tumors (not including breast and prostate cancer) or multiple myeloma. These results were presented today at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany (Abstract Number: 20LBA).
The presence in advanced breast cancer of mutational signatures characteristic of homologous recombination deficiency (HRD) was associated with improved clinical outcomes to treatment with platinum-based chemotherapy.
Bacteria responsible for middle ear infections, pink eye and sinusitis protect themselves from further immune attack by transporting molecules meant to destroy them away from their inner membrane target, according to a study from Nationwide Children's Hospital.
People living with HIV/AIDS in New Jersey could be negatively affected by prescription drug co-payments included in Gov. Jon Corzine's (D) proposed $29.8 billion budget, advocates told state lawmakers on Tuesday, the Newark Star-Ledger reports.
› Verified 7 days ago
Mrs. Darleen Dansby, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1513 Viceroy Dr, Dallas, TX 75235 Phone: 469-685-7020 Fax: 214-920-7020 | |
Ms. Kimberley Shenee Player, MSN, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8604 Greenville Ave Ste 103a, Dallas, TX 75243 Phone: 214-702-5855 | |
Teresa Anna Jones, CPNP-AC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1935 Medical District Dr, Dallas, TX 75235 Phone: 973-801-0173 | |
Christina Hagood, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6301 Gaston Ave, Suite 100, West Tower, Dallas, TX 75214 Phone: 214-827-3610 Fax: 214-821-4017 | |
Mrs. Larah Brown, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3209 W Camp Wisdom Rd, Dallas, TX 75237 Phone: 469-966-9660 Fax: 877-667-6112 | |
Michele Willet Rylander, RN, MSN, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1935 Medical District Dr, Dallas, TX 75235 Phone: 214-456-7000 |